Home / Cancer and immune system / Vinorelbine
ATC L01CA04 · Antineoplastic Agents
Vinorelbine shortage
As of 31 Oct 2026, Vinorelbine has a reported shortage in 2 of the 5 countries we track (Germany, Italy), covering 2 products.
Countries2/5
Products2packs or presentations
Short since15 Oct 202513 months ago
Earliest return31 Dec 2026company estimate
No return date1products
Main reasonManufacturing problem
Timeline
GermanyItaly
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | Bendarelbin 10 mg/ml Konzentrat zur Herstellung einer Infusionslösung | BENDALIS GmbH | 15 Oct 2025 | 31 Dec 2026 | Manufacturing problem Probleme in der Herstellung |
| IT | VINORELBINA ACCORD | ACCORD HEALTHCARE, S.L.U. | 1 May 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.